Post-approval commitment for NMPA-2021-0044. Category: Paediatric Study. Priority: medium.

Commitment ID
COM-144
Application
Authority
National Medical Products Administration
Category
Paediatric Study
Priority
medium
Status
Open
Due Date
2025-12-04
Completed At
—
Owner
Aisha Okonkwo
Created
2023-01-15
Description

Provide confirmatory bioequivalence study for 200 mg strength

Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.